In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)

Chest

Volumn 141, Issue 6, 2012, Pages 1490-1495

  Rondina, Matthew T ^a   Brewster, BreAnna ^a   Grissom, Colin K ^a,b   Zimmerman, Guy A ^a   Kastendieck, Diana H ^a   Harris, Estelle S ^a   Weyrich, Andrew S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

2009 H1N1 INFLUENZA; ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; MONOCYTE; PLATELET MONOCYTE AGGREGATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SHOCK; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 84862023500     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2860     Document Type: Article

References (30)

1. Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol. 2008;82(6):2772-2783. (Pubitemid 351329168)
2. Julkunen I, Melén K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine. 2000;19(suppl 1):S32-S37. (Pubitemid 32121717)
3. Miller RR III, Markewitz BA, Rolfs RT, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest. 2010;137(4):752-758.
4. Khandaker G, Dierig A, Rashid H, King C, Heron L, Booy R. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respir Viruses. 2011;5(3):148-156.
5. Bunce PE, High SM, Nadjafi M, Stanley K, Liles WC, Christian MD. Pandemic A(H1N1) influenza infection and vascular thrombosis. Clin Infect Dis. 2011;52(2):e14-e17.
6. Garcia CC, Russo RC, Guabiraba R, et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog. 2010;6(11):e1001171.
7. Keller TT, van der Sluijs KF, de Kruif MD, et al. Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res. 2006;99(11):1261-1269. (Pubitemid 44808663)
8. Estella A. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia. J Infect Dev Ctries. 2011;5(7):540-543.
9. Terada H, Baldini M, Ebbe S, Madoff MA. Interaction of influenza virus with blood platelets. Blood. 1966;28(2):213-228.
10. Harris ES, Rondina MT, Schwertz H, Weyrich AS, Zimmerman GA. Pathogenesis of sepsis and sepsis-induced acute lung injury. In: Choi AMK, ed. Acute Respiratory Distress Syndrome. New York, NY: Informa Healthcare USA, Inc; 2010:369-419.
11. Smyth SS, McEver RP, Weyrich AS, et al; 2009 Platelet Colloquium Participants. Platelet functions beyond hemostasis. J Thromb Haemost. 2009;7(11):1759-1766.
12. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol. 2009;40(2):123-134.
13. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001;104(13):1533-1537. (Pubitemid 32917347)
14. Vieira-de-Abreu A, Campbell RA, Weyrich AS, et al. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol. 2012;34(1):5-30.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829. (Pubitemid 15250137)
16. Mandell LA, Wunderink RG, Anzueto A, et al Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72. (Pubitemid 46290553)
17. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
18. Rello J, Pop-Vicas A. Clinical review: primary influenza viral pneumonia. Crit Care. 2009;13(6):235.
19. Ichiyama T, Morishima T, Suenaga N, Kajimoto M, Matsubara T, Furukawa S. Analysis of serum soluble CD40 ligand in patients with influenza virus-associated encephalopathy. J Neurol Sci. 2005;239(1):53-57. (Pubitemid 41617415)
20. Suchyta MR, Clemmer TP, Elliott CG, et al. Increased mortality of older patients with acute respiratory distress syndrome. Chest. 1997;111(5):1334-1339. (Pubitemid 27200093)
21. Eiland EH, Wargo KA, Hamm W, Hassoun AA. Analysis of adherence to national nosocomial pneumonia treatment guidelines. Ther Clin Risk Manag. 2007;3(6):983-988.
22. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862. (Pubitemid 43062645)
23. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(suppl 5):S378-S385. (Pubitemid 351717325)
24. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133(3):610-617. (Pubitemid 351367367)
25. Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost. 1994;72(2):302-308. (Pubitemid 24251298)
26. Oleksowicz L, Mrowiec Z, Isaacs R, Dutcher JP, Puszkin E. Morphologic and ultrastructural evidence of interleukin-6 induced platelet activation. Am J Hematol. 1995;48(2):92-99.
27. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990;75(1):40-47. (Pubitemid 20031487)
28. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest. 1997;111(5):1306-1321. (Pubitemid 27200090)
29. Rice TW, Wheeler AP, Bernard GR, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685-1694.
30. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215(4):356-362.